[1] Dumas P, Sockalingum D G, Sule-Suso J. Trends in Biotechnology, 2006, 25: 40.

[2] Miller L M, Dumas P. Biochimica et Biophysica Acta, 2006, 1758: 846.

[3] Prolla T A, Mattson M P. Trends Neurosci., 2001, 24: S21.

[4] Forno L S. J. Neuropathol. Exp. Neurol., 1996, 55: 259.

[5] Jellinger K, Braak H, Braak E, et al. Ann. N. Y. Acad. Sci., 1991, 640: 203.

[6] Apaydin H, Ahlskog J E, Parisi J E, et al. Arch. Neurol., 2002, 59: 102.

[7] Mattila P M, Rinne J O, Helenius H, et al. Acta Neuropathol., 2000, 100: 285.

[8] Mattson M P, Chan S L, Duan W. Physiol. Rev., 2002, 82: 637.

[9] Chen C T, Green J T, Orr S K, et al. Prostaglandins Leukot Essent Fatty Acids, 2008, 79: 85.

[10] Darios F, Davletov B. Nature, 2006, 440: 813.

[11] Darios F, Connell E, Davletov B. J. Physiol., 2007, 585: 699.

[12] Florent-Bechard S, Desbene C, Garcia P, et al. Biochimie, 2009, 91: 804.

[13] Bras J, Singleton A, Cookson M R, et al. Febs. J., 2008, 275: 5767.

[14] Knott C, Stern G, Wilkin G P. Mol. Cell. Neurosci., 2000, 16: 724.

[15] Balsinde J, Perez R, Balboa M A. Biochim. Biophys. Acta, 2006, 1761: 1344.

[16] Klivenyi P, Beal M F, Ferrante R J, et al. J. Neurochem., 1998, 71: 2634.

[17] Farooqui A A, Horrocks L A. Cell. Mol. Neurobiol., 1998, 18: 599.

[18] Petibois C, Deleris G. Trends Biotechnol., 2006, 24: 455.

[19] Waldbaum S, Patel M. Epilepsy. Res., 88, 23.

[20] Ross C A, Poirier M A. Nat. Med., 2004, 10(Suppl): S10.

[21] Stewart A, Factor W J W. Parkinson’s Disease: Diagnosis and Clinical Management, 2008.

[22] Zhang J, Perry G, Smith M A, et al. Am. J. Pathol., 1999, 154: 1423.

[23] Nakabeppu Y, Tsuchimoto D, Yamaguchi H, et al. J. Neurosci. Res., 2007, 85: 919.